Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Noseguard for Prevention of Respiratory Infections in Real-World Use

NCT: NCT07516977 · NOT_YET_RECRUITING

NCT IDNCT07516977
StatusNOT_YET_RECRUITING
Start Date2026-04-20
Completion2026-12-31

Brief Summary

This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions. The study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).

Frequently Asked Questions

What is Noseguard for Prevention of Respiratory Infections in Real-World Use?

Noseguard for Prevention of Respiratory Infections in Real-World Use is a clinical trial registered under NCT07516977. Current status: NOT_YET_RECRUITING.

What is the status of NCT07516977?

The current status of NCT07516977 (Noseguard for Prevention of Respiratory Infections in Real-World Use) is: NOT_YET_RECRUITING.

When did Noseguard for Prevention of Respiratory Infections in Real-World Use start?

Noseguard for Prevention of Respiratory Infections in Real-World Use started on 2026-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑